G. Mazzella

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Frederik Nevens, Pietro Andreoné, G. Mazzella et al. · New England Journal of Medicine · 2016 · 1.1K citations · Full text

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

Fabio Conti, F. Buonfiglioli, Alessandra Scuteri et al. · Journal of Hepatology · 2016 · 888 citations · Full text

Hepatology, Hepatitis C, Viral Hepatitis +13

Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status

Franco Trevisani, Paola E. D'Intino, Antonio Maria Morselli‐Labate et al. · Journal of Hepatology · 2001 · 736 citations

Hepatic Disorders, Hepatology, Viral Hepatitis +11

Sustained virological response to interferon-α is associated with improved outcome in HCV-related cirrhosis: A retrospective study

Savino Bruno, Tommaso Stroffolini, Massimo Colombo et al. · Hepatology · 2007 · 602 citations · Full text